Dr. Ganapathi carries out research in two areas: 

  1. Immunocompromised/Transplant Infectious diseases: Dr. Ganapathi is involved in clinical research pertaining to infections in transplant recipients. This includes outcomes and quality improvement studies.
  2. Global Health: Dr. Ganapathi is initiating new projects with collaborators in India to improve linkage to care for adolescent injection drug users in various cities in North-East and North India. This work will also involve interventions to prevent early initiation into injecting drug use as well as harm reduction strategies, which are integral to prevent the spread of HIV and Hepatitis C in this population.


Dr. Ganapathi is dual trained in Infectious Diseases and Nephrology. Her clinical expertise is in infections affecting immunocompromised children and adolescents, including solid organ and stem cell transplant recipients. She also spends a part of her clinical time attending on the General Pediatrics Hospitalist Service. She has served on the Executive Committee of the Infectious Diseases Community of practice at the American Society of Transplantation, where she was involved in national initiatives. Dr. Ganapathi continue to work with both the AST and PIDS special interest groups to develop pediatric transplant infectious diseases specific curricula. She continues to also be involved in various global health education initiatives both locally as well as internationally.


Publications powered by Harvard Catalyst Profiles

  1. Trends in Pediatric Candidemia: Epidemiology, Anti-Fungal Susceptibility, and Patient Characteristics in a Children's Hospital. J Fungi (Basel). 2021 Jan 22; 7(2). View abstract
  2. Medical Deferred Action - Living on Borrowed Time. N Engl J Med. 2019 Oct 24; 381(17):1601-1603. View abstract
  3. Impact of standardized protocols for cytomegalovirus disease prevention in pediatric solid organ transplant recipients. Pediatr Transplant. 2019 11; 23(7):e13568. View abstract
  4. Young people who inject drugs in India have high HIV incidence and behavioural risk: a cross-sectional study. J Int AIDS Soc. 2019 05; 22(5):e25287. View abstract
  5. Trainee Needs in Pediatric Transplant Infectious Diseases Education. J Pediatric Infect Dis Soc. 2017 Sep 01; 6(3):301-304. View abstract
  6. Perspectives of host faculty and trainees on international visiting faculty to paediatric academic departments in East Africa. BMJ Glob Health. 2016; 1(3):e000097. View abstract
  7. Use of cidofovir in pediatric patients with adenovirus infection. F1000Res. 2016; 5:758. View abstract
  8. In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant. Cytokine. 2016 07; 83:99-109. View abstract
  9. IMAGES IN CLINICAL MEDICINE. A Child with Gross Hematuria. N Engl J Med. 2015 Aug 27; 373(9):e11. View abstract
  10. The Imidazoquinoline Toll-Like Receptor-7/8 Agonist Hybrid-2 Potently Induces Cytokine Production by Human Newborn and Adult Leukocytes. PLoS One. 2015; 10(8):e0134640. View abstract
  11. Overcoming challenges to develop pediatric postgraduate training programs in low- and middle-income countries. Educ Health (Abingdon). 2014 Sep-Dec; 27(3):277-82. View abstract
  12. An adolescent presenting with a pleural mass. Clin Pediatr (Phila). 2014 May; 53(5):504-6. View abstract
  13. Factors associated with encephalopathy in patients with Salmonella enterica serotype Typhi bacteremia presenting to a diarrheal hospital in Dhaka, Bangladesh. Am J Trop Med Hyg. 2012 Apr; 86(4):698-702. View abstract